Wright Medical Group N.V. (NASDAQ:WMGI) – Jefferies Group reduced their FY2017 earnings per share estimates for Wright Medical Group N.V. in a note issued to investors on Wednesday. Jefferies Group analyst R. Denhoy now anticipates that the medical device company will post earnings per share of ($0.31) for the year, down from their prior estimate of ($0.29). Jefferies Group currently has a “Buy” rating on the stock. Jefferies Group also issued estimates for Wright Medical Group N.V.’s Q4 2017 earnings at $0.01 EPS, Q1 2018 earnings at ($0.03) EPS, Q2 2018 earnings at ($0.01) EPS, Q3 2018 earnings at ($0.08) EPS, Q4 2018 earnings at $0.11 EPS, FY2018 earnings at ($0.01) EPS, FY2019 earnings at $0.40 EPS and FY2020 earnings at $0.65 EPS.

Wright Medical Group N.V. (NASDAQ:WMGI) last posted its earnings results on Wednesday, November 1st. The medical device company reported ($0.16) EPS for the quarter, hitting analysts’ consensus estimates of ($0.16). Wright Medical Group N.V. had a negative net margin of 38.40% and a negative return on equity of 6.27%. The business had revenue of $170.50 million during the quarter, compared to the consensus estimate of $173.50 million. During the same quarter in the previous year, the firm posted ($0.19) EPS. The firm’s revenue was up 8.4% on a year-over-year basis.

COPYRIGHT VIOLATION NOTICE: This piece was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.watchlistnews.com/equities-analysts-issue-forecasts-for-wright-medical-group-n-v-s-fy2017-earnings-wmgi/1684088.html.

Other equities research analysts also recently issued research reports about the stock. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $30.00 target price on shares of Wright Medical Group N.V. in a research report on Thursday, November 2nd. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $34.00 target price on shares of Wright Medical Group N.V. in a research report on Thursday, August 3rd. Robert W. Baird reaffirmed a “buy” rating and issued a $33.00 target price on shares of Wright Medical Group N.V. in a research report on Friday, October 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Wright Medical Group N.V. in a research report on Friday, September 1st. Finally, BidaskClub raised shares of Wright Medical Group N.V. from a “sell” rating to a “hold” rating in a research report on Friday, August 11th. Six equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Wright Medical Group N.V. presently has an average rating of “Buy” and a consensus target price of $32.22.

Shares of Wright Medical Group N.V. (NASDAQ:WMGI) opened at $25.12 on Monday. The company has a debt-to-equity ratio of 1.52, a current ratio of 1.31 and a quick ratio of 0.96. Wright Medical Group N.V. has a 1 year low of $20.69 and a 1 year high of $31.53.

Hedge funds have recently modified their holdings of the company. Blue Jay Capital Management LLC grew its position in shares of Wright Medical Group N.V. by 4.7% during the 2nd quarter. Blue Jay Capital Management LLC now owns 320,420 shares of the medical device company’s stock valued at $8,808,000 after acquiring an additional 14,255 shares during the period. Victory Capital Management Inc. lifted its stake in shares of Wright Medical Group N.V. by 30.6% during the 2nd quarter. Victory Capital Management Inc. now owns 1,039,308 shares of the medical device company’s stock valued at $28,571,000 after buying an additional 243,630 shares in the last quarter. Capital Research Global Investors lifted its stake in shares of Wright Medical Group N.V. by 60.9% during the 2nd quarter. Capital Research Global Investors now owns 2,775,000 shares of the medical device company’s stock valued at $76,285,000 after buying an additional 1,050,000 shares in the last quarter. Westfield Capital Management Co. LP lifted its stake in shares of Wright Medical Group N.V. by 13.8% during the 2nd quarter. Westfield Capital Management Co. LP now owns 2,425,566 shares of the medical device company’s stock valued at $66,679,000 after buying an additional 293,687 shares in the last quarter. Finally, Northern Trust Corp lifted its stake in shares of Wright Medical Group N.V. by 3.4% during the 2nd quarter. Northern Trust Corp now owns 1,865,977 shares of the medical device company’s stock valued at $51,296,000 after buying an additional 60,840 shares in the last quarter.

Wright Medical Group N.V. Company Profile

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Earnings History and Estimates for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.